Scientists have reported a blood biomarker test that could be used to identify individuals with multiple sclerosis whose condition is likely to deteriorate in the following year.
Scientists from Prokhorov General Physics Institute of the Russian Academy of Sciences (Moscow, Russia) and the Moscow Institute of Physics and Technology (Russia) have developed a new tool to that could improve the diagnosis and monitoring of autoimmune disorders.
Thermo Fisher Scientific (MA, USA), WuXi Diagnostics (Shanghai, China) and Mayo Clinic (MN, USA) are collaborating to develop and validate a serology test for COVID-19.
Emergency use authorization for Thermo Fisher Scientific’s COVID-19 diagnostic test expanded by US FDA
The US FDA has expanded the emergency use authorization granted to Thermo Fisher Scientific’s (MA, USA) COVID-19 diagnostic test. The expansion could facilitate workflow flexibility and increase test throughput.
Researchers have developed a tool that could help to monitor the spread of infectious diseases. The newly developed blood test could provide information about whether and when an individual has been exposed to infection.
Mologic (Bedford, UK) and BioSure (Essex, UK) have entered a partnership to produce an antibody self-test for COVID-19 that does not require specialist equipment or training to carry out.
A study led by researchers from Brussels Academic Hospital Lab (LHUB-ULB, Brussels, Belgium) indicates that the COVID-19 Ag Respi-Strip® – an antigen test for COVID-19 – could be a useful component in broader testing strategies.
Medicines Discovery Catapult (Cheshire, UK), Retrogenix (High Peak, UK) and Peak Proteins (Cheshire, UK) have entered a new three-way collaboration to identify potential target receptors for COVID-19 therapies.
Researchers from Icahn School of Medicine at Mount Sinai (NY, USA) have developed a step-by-step protocol for a serological test that can detect antibodies to SARS-CoV-2.
Results of a new multi-institutional study led by researchers at University of Illinois at Urbana-Champaign (IL, USA) indicate that a portable testing device clipped to a smartphone could detect pathogens in biological samples in minutes.